Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

TRPM4 protein expression in prostate cancer - a novel tissue biomarker associated with risk of biochemical recurrence following radical prostatectomy.

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Methodological approach to Microscopic Colitis diagnosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Lymphomas of the head and neck region: an update

    Research output: Contribution to journalReviewResearchpeer-review

  3. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. AZGP1 Protein Expression in Hormone-Naïve Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Prognostic implication of gait function following treatment for spinal cord compression in men diagnosed with prostate cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Predictive value of combined analysis of pro-NPY and ERG in localized prostate cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Transient receptor potential cation channel, subfamily M, member 4 (TRPM4) messenger RNA (mRNA) has been shown to be upregulated in prostate cancer (PCa) and might be a new promising tissue biomarker. We evaluated TRPM4 protein expression and correlated the expression level with biochemical recurrence (BR) following radical prostatectomy (RP).

MATERIAL AND METHODS: The study included 614 patients who had undergone RP. TRPM4 immunohistochemical staining was performed on samples of benign tissue, tissue containing PIN glands and PCa tissue using a commercially available polyclonal antibody. Staining intensity was recorded by two independent observers using a four-tired semi-quantitative grading system (0, 1+, 2+, 3+) converted into H-scores. Interobserver agreement was calculated by linear weighted kappa statistics. The association between staining intensity and BR was analysed using the Kaplan-Meier estimator and uni- and multiple Cox proportional hazard regression models.

RESULTS: Significantly higher staining intensity was found in PCa glands compared to benign glands (p < 0.001). The concordance rate in TRPM4 staining intensities for benign, PIN and PCa tissue ranged from 86.0 to 91.5 %, corresponding to linear weighted kappa values of 0.566-0.789. After adjusting for patient and tumour characteristics, patients with a higher staining intensity in PCa glands compared to matched benign glands and an H-score equal to or above the median had an increased risk of BR (HR 1.79-2.62; p = 0.01-0.03 for the two observers) when compared to patients with a lower staining intensity.

CONCLUSIONS: TRPM4 protein expression is widely expressed in benign and cancerous prostate tissue, with highest staining intensities found in PCa. Overexpression of TRPM4 in PCa (combination of high staining intensity and a high H-score) is associated with increased risk of BR after RP.

Original languageEnglish
JournalVirchows Archiv : an international journal of pathology
Volume468
Issue number3
Pages (from-to)345-55
Number of pages11
ISSN0945-6317
DOIs
Publication statusPublished - Mar 2016

ID: 46502217